Leukocyte Adherence Inhibition Test (LAI)

This test checks how well your body's white blood cells can fight cancer. It looks at how well they stick to a surface when mixed with cancer cells. It also checks if your blood can block this sticking process. This helps doctors understand your immune system's ability to fight cancer.

Procedure

What people who've had Leukocyte Adherence Inhibition Test (LAI) report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Leukocyte Adherence Inhibition Test (LAI)

Who It's For

The leukocyte adherence inhibition (LAI) test is a laboratory blood test designed to detect whether the immune system has become sensitized to a cancer or another specific substance. Leukocytes, the white blood cells that defend the body, normally stick to glass. In the LAI test, a person's white blood cells are mixed with an extract made from a tumor of the same type being looked for. If the cells have previously been primed against that tumor, they stick less to glass, and that drop in stickiness is read as a positive result. A related version tests the person's serum (the liquid part of blood) to see whether it contains factors that block this reaction. The test was studied mainly in research settings from the 1970s to the early 1990s, in cancers of the colon and rectum, breast, lung, stomach, pancreas, liver, ovary and mouth. Smaller studies also tried it for house dust mite allergy and the parasitic infection schistosomiasis. Results varied widely between studies, cancer types and laboratory methods. Some groups reported that it picked up many early cancers, while others concluded it was of little or limited value for diagnosis. Because of that inconsistency, an LAI result cannot confirm or rule out cancer on its own. Diagnosing cancer still depends on standard approaches such as imaging and a biopsy, and cancer screening relies on recommended screening tests.

Before the Procedure

The test needs only a blood sample, and published descriptions do not call for special preparation such as fasting. Follow any instructions from the clinic or laboratory, and let them know what medicines you take. Do not stop or change a medicine without talking to your prescriber first. Because this is an uncommon research-era test, it is reasonable to ask before the draw which laboratory will run it, what the result would be used for, and whether insurance covers it.

During the Procedure

A health care worker draws blood from a vein, usually on the inside of the elbow or the back of the hand. An elastic band is tied around the upper arm to make the vein easier to find, the skin is cleaned, and a needle collects the blood into a tube. Most people feel a brief sting or slight pain as the needle goes in. The draw itself takes a few minutes. The actual testing happens later in the laboratory, where the white blood cells are separated, exposed to the tumor or antigen extract and then measured for how well they stick to glass compared with control samples.

Recovery & Aftercare

Most people return to normal activities right away. Some throbbing, tenderness or a small bruise where the needle went in is common and usually fades quickly. The ordering clinician interprets the result. Because studies found both false positives and false negatives, a result is most useful as one piece of information alongside symptoms, imaging and, where needed, a biopsy, rather than as a stand-alone answer.

Risks & Complications

The physical risk is that of an ordinary blood draw, which is very small: slight pain or bruising at the needle site that usually goes away quickly. The more important risk is a misleading result. In research studies, people with noncancerous conditions such as active tuberculosis or benign liver disease sometimes tested positive, which could cause needless worry or further testing. People with cancer could also test negative, and in several studies the test was less likely to be positive as cancer became larger or more advanced. A negative result therefore should not be taken as reassurance that cancer is absent, and a positive result is not a diagnosis.

Questions to Ask Your Doctor

  1. 1.What question is this test meant to answer for me, and how would the result change what we do next?
  2. 2.Which laboratory runs this test, and how well has its version been validated?
  3. 3.What standard tests, such as imaging, a biopsy or a recommended screening test, would answer the same question?
  4. 4.If my result is negative, what would still make you want to look further?
  5. 5.Will my insurance cover this test, and what will it cost if not?

Last reviewed • Oct 2026

Educational content, not medical advice.